LoginSignup
CEV

CellaVision Stock

StockStock
ISIN: SE0000683484
Ticker: CEVI
SE0000683484
CEVI

Price

Historical dividends and forecast

All dividend data

CellaVision has so far distributed $0.207 in 2024. The next dividend will be paid on 13.05.2025

$0.147

CHART BY

Frequently asked questions

What is CellaVision's market capitalization?

The market capitalization of CellaVision is $518.25M. Market capitalization is a measure of the total market value of a publicly traded company. It is calculated by multiplying the current stock price by the total number of outstanding shares.

What is CellaVision's Price-to-Earnings (P/E) ratio?

The Price-to-Earnings (P/E) ratio (TTM) for CellaVision is 37.95. This ratio helps investors assess whether a stock is overvalued or undervalued compared to its earnings.

What is the Earnings Per Share (EPS) for CellaVision?

CellaVision's Earnings Per Share (EPS) over the trailing twelve months (TTM) is $0.573. EPS indicates the company's profitability on a per-share basis.

What are the analyst ratings and target price for CellaVision's stock?

Currently, 3 analysts cover CellaVision's stock, with a consensus target price of $23.64. Analyst ratings provide insights into the stock's expected performance.

What is CellaVision's revenue over the trailing twelve months?

Over the trailing twelve months, CellaVision reported a revenue of $67.02M.

What is the EBITDA for CellaVision?

CellaVision's Earnings before interest, taxes, depreciation, and amortization (EBITDA) over the trailing twelve months is $20.96M. EBITDA measures the company's overall financial performance.

What is the free cash flow of CellaVision?

CellaVision has a free cash flow of $8.98M. Free cash flow indicates the cash generated after accounting for cash outflows to support operations and capital assets.

What is the 5-year beta of CellaVision's stock?

The 5-year beta for CellaVision is 1.22. A beta value indicates the stock's volatility relative to the market; a beta greater than 1 means higher volatility.

How many employees does CellaVision have, and what sector and industry does it belong to?

CellaVision employs approximately 228 people. It operates in the Health Care sector, specifically within the Medical Equipment & Supplies industry.

What is the free float of CellaVision's shares?

The free float of CellaVision is 19.71M. Free float refers to the number of shares available for public trading, excluding restricted shares.

Financials

Market Cap

 $518.25M

5Y beta

 1.22

EPS (TTM)

 $0.573

Free Float

 19.71M

P/E ratio (TTM)

 37.95

Revenue (TTM)

 $67.02M

EBITDA (TTM)

 $20.96M

Free Cashflow (TTM)

 $8.98M

Pricing

1D span
$21.46$22.74
52W span
$15.22$28.56

Analyst Ratings

The price target is $23.64 and the stock is covered by 3 analysts.

Buy

1

Hold

2

Sell

0

Information

CellaVision AB is a Sweden-based company active in the medical technology sector. The Company develops and sells digital solutions for medical microscopy, as well as products enabling blood cell analysis and morphology diagnosis. CellaVision AB’s product portfolio consists of analyzers for automated medical microscopy analysis and software applications designed for remote access, competency testing and education. The analyzers include such brands as CellaVision DM96 and CellaVision DM1200, whereas the software applications are divided into CellaVision Body Fluid Application, CellaVision Remote Review Software and CellaVision Competency Software, among others. The Company operates four subsidiaries, based in Sweden, Canada, the United States and Japan. In June 2014, CellaVision AB acquired technology platform from Clear Lake Medical Foundation.

228

Medical Equipment & Supplies

Health Care

Identifier

ISIN

SE0000683484

Primary Ticker

CEVI

Knockouts

Join the conversation
Sign upLogin